They are a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases
Last Closing Price
February 8, 2018
Cowen, Piper Jaffray
To view the prospectus for Adverum Biotechnologies, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277